Stephen Rankin

Dr. Stephen Rankin is an Honorary Clinical Lecturer at the University of Glasgow's School of Medicine, Dentistry & Nursing. His research focuses on cardio-oncology, cardiovascular medicine, and clinical imaging. He has contributed to studies on anthracycline-induced cardiotoxicity, immune checkpoint inhibitors' cardiovascular effects, and PET imaging techniques for atherosclerosis. His work bridges oncology and cardiology, emphasizing drug safety and patient outcomes in high-risk populations. Key publications include investigations into arterial structural changes in lymphoma patients and eligibility criteria for combination cancer therapies. No scientific awards are explicitly mentioned, though his research has been published in prominent journals like Clinical Science and JACC: CardioOncology. He collaborates with NHS GGC and international researchers, contributing to both clinical and preclinical studies.